The present patent application relates a process for the production of compressed tablets using specific coated particles, wherein the coating (system) comprises at least one wax and/or at least one fat. Furthermore it relates to compressed (compacted) tablets and as well as to specific coated particles.

The present patent application relates a process for the production of compressed tablets using specific coated particles, wherein the coating (system) comprises at least one wax and/or at least one fat. Furthermore it relates to compressed (compacted) tablets and as well as to specific coated particles.

Compositions and methods for increasing absorption of nutrients by a body. A composition includes a liposome comprising a lipid bilayer, wherein the liposome comprises an internal core. The composition includes a nutrient payload disposed within the liposome. The nutrient payload comprises a plurality of different supplement nutrients comprising one or more of a vitamin, mineral, extract, enzyme, or amino acid.

Compositions and methods for increasing absorption of nutrients by a body. A composition includes a liposome comprising a lipid bilayer, wherein the liposome comprises an internal core. The composition includes a nutrient payload disposed within the liposome. The nutrient payload comprises a plurality of different supplement nutrients comprising one or more of a vitamin, mineral, extract, enzyme, or amino acid.

Disclosed herein are prenatal dosage forms formulated for different stages of the pregnancy cycle. Also disclosed are methods of administering prenatal dosage forms to a prenatal, pregnant or lactating woman. Further disclosed are kits including prenatal dosage forms.

Disclosed herein are prenatal dosage forms formulated for different stages of the pregnancy cycle. Also disclosed are methods of administering prenatal dosage forms to a prenatal, pregnant or lactating woman. Further disclosed are kits including prenatal dosage forms.

Disclosed herein are prenatal dosage forms formulated for different stages of the pregnancy cycle. Also disclosed are methods of administering prenatal dosage forms to a prenatal, pregnant or lactating woman. Further disclosed are kits including prenatal dosage forms.

Brain-derived neurotrophic factor (BDNF) is known to be related to normal neuronal function and energy homeostasis, and increased levels of serum BDNF are associated with improved cognitive function, including learning and memory. The present invention relates generally to a method of preparing compositions for increasing the serum levels of brain-derived neurotrophic factor (BDNF). In particular, the method relates to combining a curcuminoid or a derivative thereof with a dispersing agent under high shear, and administering the composition to a subject in need thereof to increase the serum levels of Brain-derived neurotrophic factor (BDNF) to improve cognitive function, wherein the composition may be co-administered with iron.

Brain-derived neurotrophic factor (BDNF) is known to be related to normal neuronal function and energy homeostasis, and increased levels of serum BDNF are associated with improved cognitive function, including learning and memory. The present invention relates generally to a method of preparing compositions for increasing the serum levels of brain-derived neurotrophic factor (BDNF). In particular, the method relates to combining a curcuminoid or a derivative thereof with a dispersing agent under high shear, and administering the composition to a subject in need thereof to increase the serum levels of Brain-derived neurotrophic factor (BDNF) to improve cognitive function, wherein the composition may be co-administered with iron.

Clay delivery systems for providing antimicrobial compositions are provided. The delivery systems include a two-part active excipient system that delivers clay for various applications of use, including topical applications. The two-part delivery system can include a first part comprising suspending agent(s), poloxamer and optionally a gellant, and a second part that is simultaneously delivered therewith comprising one or more nonionic EO-PO block copolymers in a water-based system. The delivery systems beneficially provide clays in a stable system that also unexpectedly accelerate the release of the clay into the water system for activation and delivery that is enhanced by the poloxamers into the tissue or organ of the body in need of treatment thereof.